Africa Oil Corp. ("Africa Oil", or the "Company") is pleased to announce that the Company repurchased a total of 864,200 ...

Nasdaq Stockholm has decided that Probi AB will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on 12 February 2025.For further information, please contact: Anita Johan ...

The Company is requesting the approval from holders of its maximum EUR 28,500,000 senior secured callable fixed rate bonds 2020/2028 with ISIN SE0013801172 (hereinafter referred ...

Between January 27, 2025, and January 31, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

Nobia Holdings UK, the company behind the Magnet kitchen brand, has not made a pre-tax profit since 2019 and has seen ...

Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...

Stockholm, 3rd of February 2025 - Today Virtune announces that it has finalized its monthly rebalancing for Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm and Nasdaq Helsinki (ISIN code ...

The group behind kitchen maker Magnet is hoping expanding into the premium market will help it return to profit after falling to another huge loss and cutting hundreds of jobs. Nobia Holdings UK, the ...

With a continued positive trend in customer traffic and higher volumes, Axfood is summarising a fourth quarter, and full year, characterised by stronger market positions. At the same time, strategical ...

Financial development & significant events during the second quarter (1 Oct - 31 Dec) Sales growth in local currencies amounted to 11 percent.Net sales for the period increased by 12 percent and amoun ...

The rise of DeepSeek, a Chinese AI start-up developed at a fraction of the cost of its US counterparts. News of its success ...

Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...